COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 489: Articles 4881-4890  | Next

Durable reprogramming of neutralising antibody responses following breakthrough Omicron infection
Lee, W. S., Tan, H.-X., Reynaldi, A., Esterbauer, R., Koutsakos, M., Nguyen, J., Amarasena, T., Kent, H. E., Aggarwal, A., Turville, S. G., Taiaroa, G., Kinsella, P., Liew, K. C., Tran, T., Williamson, D. A., Cromer, D., Davenport, M. P., Kent, S. J., Juno, J. A., Khoury, D. S., Wheatley, A. K.
10.1101/2023.02.19.23286159 — Posted: 2023-02-24
Bivalent COVID-19 vaccine antibody responses to Omicron variants suggest that responses to divergent variants would be improved with matched vaccine antigens
Wang, W., Goguet, E., Paz Padilla, S., Vassell, R., Pollett, S., Mitre, E., Weiss, C.
10.1101/2023.02.22.23286320 — Posted: 2023-02-24
Design of logistics Indicators for Monitoring the Covid-19 Vaccination Process in Colombia
Velasco, N., Herrera, A., Trujillo Diaz, J., Amaya, C.-A., Gonzalez-Uribe, C., Hernandez, E.
10.1101/2023.02.23.23286347 — Posted: 2023-02-23
The Impact of COVID-19 on Cancer Screening and Treatment in Older Adults: The Multiethnic Cohort Study
Mak, V. P., White, K., Wilkens, L. R., Cheng, I., Haiman, C. A., Le Marchand, L.
10.1101/2023.02.19.23286150 — Posted: 2023-02-23
Understanding the impact of a social support program in Immokalee, FL, during the COVID-19 pandemic
Richards, L., Wang, L., Jeanmarie, J., Shafazand, S., Palazuelos, D., Monacello, V.
10.1101/2023.02.23.23286348 — Posted: 2023-02-23
PREVALENCE OF DEPRESSION AND ANXIETY IN COLOMBIA: WHAT HAPPENED DURING COVID-19 PANDEMIC?
Martinez-Cabezas, S., Pinilla-Roncancio, M., Carrasquilla, G., Casas, G., Gonzalez-Uribe, C.
10.1101/2023.02.23.23286343 — Posted: 2023-02-23
Peruvian National Survey of Mental Health and Service Utilization in the third year of the COVID-19 pandemic: Protocol for a nationally representative multistage survey
Cruz, V. O., Pariamachi, A., Napanga, N., Pena, B., Gamboa, L., Gonzales, C., Delgado, P., Burela, P. A., Villa-Palomino, J., Valentin, L., Zuniga, D., Quispe, O., Lopez, P., Alcantara, J., Bonilla, N., Anton, S., Gutierrez, M., Diaz, C., Claux, J., Gonzales, A., Vivar, R., Lobe, G., Contreras, E., Mahr, B., Pampamallco, M., Salazar, S., Santos, M., Valentin, V., Arias, J. P., Alvarez, M., Amaro, C., Calderon, K., Canchis, J., Carbajal, F., Chire, J., Correa, L., Hermoza, L., Moron, G., Palomino, C., Ramirez, R., Rojas, E., Arevalo, M., Arellano, C., Herrera, V., Ricardi, J., Gupio, G., Jaramillo, O., Clapes, C., Cerna, E., Antunez, M., Luna, F., Saavedra, A., Carbajal, S., Vega, F., Ruiz, P., Saavedra, J., Luna, E., Del-Campo, J., Familiar-Lopez, I., Ametaj, A. A., Copeland, W. E., Anthony, J., Nishimura, R., Tiemeier, H., Gelaye, B.
10.1101/2023.02.22.23286197 — Posted: 2023-02-23
A unique cytotoxic CD4+ T cells signature defines critical COVID-19
Baird, S., Ashley, C. L., Marsh-Wakefield, F., Alca, S., Ashhurst, T. M., Ferguson, A. L., Lukeman, H., Counoupas, C., Post, J. J., Konecny, P., Bartlett, A., Martinello, M., Bull, R. A., Lloyd, A., Grey, A., Hutchings, O., Palendira, U., Britton, W. J., Steain, M., Triccas, J. A.
10.1101/2023.02.17.23286059 — Posted: 2023-02-23
Evidence of Leaky Protection Following COVID-19 Vaccination and SARS-CoV-2 Infection in a US Correctional Facility Population
Lind, M. L., Dorion, M., Houde, A. J., Lansing, M., Lapidus, S., Thomas, R., Yildirim, I., Omer, S. B., Schulz, W. L., Andrews, J. R., Hitchings, M. D., Kennedy, B. S., Richeson, R. P., Cummings, D. A., Ko, A. I.
10.1101/2023.02.17.23286049 — Posted: 2023-02-23
Multilevel determinants of Covid-19 vaccine hesitancy and undervaccination among marginalized populations in the United States: A scoping review
Newman, P. A., Nyoni, T., Allan, K., Fantus, S., Dinh, D., Tepjan, S., Reid, L., Guta, A.
10.1101/2023.02.23.23286342 — Posted: 2023-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).